Pamela D. Garzone, Ph.D.
Pamela D. Garzone is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the level of Chief Medical Officer. She has led teams successfully through the regulatory process, culminating in the clearance of multiple INDs in different therapeutic areas and approval of…...
Mien-Chie Hung, Ph.D.
Mien-Chie Hung received undergraduate and graduate degrees from National Taiwan University and his Ph.D. from Brandeis University. After completing postdoctoral training with Dr. Robert A. Weinberg at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology, Dr. Hung was recruited to the University of Texas’s MD Anderson…...
Brian Leyland-Jones, MBBS, Ph.D.
Brian Leyland-Jones, BSc (Ist class Hons), MBBS, PhD, FRACP, FRCPC is the Chief Medical Officer of AIM-HI Accelerator Fund and the N OF 1 Mission, CSO of The Darwin Foundation, collectively devoted to the implementation of prevention and cure of malignancy globally. He sits on several national and international boards…...
Min Li, Ph.D.
Dr. Min Li is George Lynn Cross Research Professor of Medicine, Surgery, and Cell Biology at The University of Oklahoma Health Sciences Center (OUHSC), and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Assistant Dean for International Research Collaboration at the College of Medicine, and…...
AFCR is registered in Hong Kong with the Inland Revenue Department. Our file number with the Inland Revenue Department is 91/7750. AFCR has a Certificate of Incorporation number 994957 with Company Registry.